MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pediatrneurol.2015.02.023

Медицинская библиотека · Pediatric neurology · 2015

Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.

Yamada Hiroyuki, Nishida Yoshinobu, Maihara Toshiro, Sa'adah Nihayatus, Harahap Nur Imma Fatimah, Nurputra Dian Kesumapramudya, Ar Rochmah Mawaddah, Nishimura Noriyuki, Saito Toshio, Kubo Yuji, Saito Kayoko, Nishio Hisahide

Клинический случайСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Spinal muscular atrophy is caused by survival motor neuron gene SMN1 mutations. SMN1 produces a full-length SMN1 protein isoform encoded by exons 1-7, and an axonal-SMN protein isoform encoded by exons 1-3 and intron 3. The axonal-SMN protein is expressed only in the embryonic period and plays a significant role in axonal growth. However, there has been no report on contribution of axonal-SMN to spinal muscular atrophy severity until now.

PATIENTS: Two Japanese boys with spinal muscular atrophy type 1 in our study presented with generalized muscle weakness and respiratory insufficiency soon after birth and required an artificial ventilator from early infancy. Patient 1 was compound heterozygous for two SMN1 mutations, whole-gene deletion, and an intragenic mutation (c.819_820insT). He retained one copy of SMN1 producing the N-terminal part of SMN1 including axonal-SMN. On the other hand, patient 2 was homozygous for SMN1 deletion. Both of them showed the same copy number of spinal muscular atrophy-modifying genes, NAIP and SMN2. These findings suggested that the C-terminal domain of full-length SMN1 determined the severity, irrespective of presence or absence of axonal-SMN expression.

CONCLUSION

In patient 1, the C-terminal domain of full-length SMN1 determined spinal muscular atrophy severity, rather than the axonal-SMN, one copy of which could be present and intact. The presence or absence of axonal-SMN may not impact disease severity in spinal muscular atrophy type 1 patients.

Для цитирования: Yamada Hiroyuki, Nishida Yoshinobu, Maihara Toshiro, Sa'adah Nihayatus, Harahap Nur Imma Fatimah, Nurputra Dian Kesumapramudya, Ar Rochmah Mawaddah, Nishimura Noriyuki, Saito Toshio, Kubo Yuji, Saito Kayoko, Nishio Hisahide. Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.. Pediatric neurology. 2015. DOI: 10.1016/j.pediatrneurol.2015.02.023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.